In response to their recent global reorganization, our client committed to becoming more competitive and patient-centric, despite operating with more limited resources. The Competitive Leadership program centered around addressing our client’s key business questions (KBQs) related to market performance, growth drivers, and prioritization to achieve sustainable growth.

Our client has a mature product with multiple indications, but the market has seen an influx of new strong competitors in recent years. As expected, HCP perceptions tend to favor the new strong brands and their promoting companies.

Through the Competitive Leadership program, it became evident that our client’s greatest strength lies in its legacy as a trusted institution within these markets, particularly in its long-standing relationships with HCPs and its deep understanding of their needs.

Working closely with the client, we developed an action plan that leveraged these strengths and focused on an even stronger personalization of their approach towards HPCs. This targeted approach delivered measurable results, including being the only brand on the market that managed to increase its share in a six months period.